Erythritol powder airflow for the treatment of peri‐implant mucositis: A randomized controlled clinical trial
International Journal of Dental Hygiene · 2024-11 · 22 (4) · 982-990
DOI: 10.1111/idh.12814 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Dental Hygiene, online erschienen am 24.04.2024. Verfasst von Stefano Corbella und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Erythritol, Chlorhexidine, Powders, Peri-Implantitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Objectives
Peri‐implant mucositis is a biofilm‐related, reversible inflammatory disease that can evolve into peri‐implantitis if not adequately treated. The aim of the present randomized controlled clinical trial was to evaluate the efficacy of air‐abrasive powder as compared to chlorhexidine (CHX) for the treatment of peri‐implant mucositis, in terms of clinical and patient‐reported outcomes (PROMs) and occurrence of peri‐implantitis 12 months after treatment.
Methods
In the control group, full‐mouth calculus and plaque removal was performed with ultrasound and manual devices, and a 1.0% CHX gel was applied; in the test group, supra‐ and subgingival biofilm removal was performed using erythritol powder with a dedicated nozzle and calculus removal was performed with ultrasonic instruments if needed. Bleeding and plaque indexes, peri‐implant probing depth and tissue level were measured at 1 week, and 1, 3, 6 and 12 months after treatment, while PROMs were evaluated up to 7 days after treatment.
Results
Among 80 included implants, 70 were analysed at 12 months follow‐up (30 in the test group, 40 in the control group, and 20 subjects). Success rates (implant‐level) in terms of bleeding index were significantly different between the test (96.7%) and control group (92.5%); as for PROMs, only taste sensation was significantly better in the test group. The test group was significantly correlated to the smallest changes in peri‐implant probing depth between baseline and 3 months.
Conclusions
The study showed that both treatment strategies are effective. This suggests that the use of air‐abrasive powders could be used as an alternative biofilm removal method instead of adjunctive treatments with antiseptics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
- IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
ORCID-Profile: Alice Alberti
Zitieren
APA
Corbella, S., Radaelli, K., Alberti, A., Francetti, L., & Taschieri, S. (2024). Erythritol powder airflow for the treatment of peri‐implant mucositis: A randomized controlled clinical trial. International Journal of Dental Hygiene, 22(4), 982-990. https://doi.org/10.1111/idh.12814
Vancouver
Corbella S, Radaelli K, Alberti A, Francetti L, Taschieri S. Erythritol powder airflow for the treatment of peri‐implant mucositis: A randomized controlled clinical trial. International Journal of Dental Hygiene. 2024;22(4):982-990. doi:10.1111/idh.12814
BibTeX
@article{Corbella2024,
author = {Corbella, Stefano and Radaelli, Katherine and Alberti, Alice and Francetti, Luca and Taschieri, Silvio},
title = {Erythritol powder airflow for the treatment of peri‐implant mucositis: A randomized controlled clinical trial},
journal = {International Journal of Dental Hygiene},
year = {2024},
volume = {22},
number = {4},
pages = {982--990},
doi = {10.1111/idh.12814}
}
EUVIMED